Alcon, Inc. Product Pipeline Analysis

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

Alcon, Inc. Product Pipeline Analysis
Published on January 2009

Report Summary


Summary

This report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and investigational products. The
report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary
end-points and trial results for products in development.

Scope

' Details of development stage by sector and equipment type.
' Pipeline products grouped by therapy area, development stage and trial phase.
' Detailed information on clinical trials covering trial phase, description, investigator information, primary and secondary end-points
and trial results.
' Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
' Product updates covering estimated approval dates and estimated launch dates.
' Descriptions of novel technologies relating to pipeline products of the company.
' Patents and patent applications covered for the product.
' News updates on key events relating to the product and its development.

Reasons to buy

' A single source to fulfill competitor information relating to products in development.
' Identify pipeline products that are potential competitor to your product lines.
' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
' Access clinical trial information to map trial results and plan targeted marketing activities.
' Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product
pipelines.
' Identification of potential investment opportunities.
' Build up knowledge base for potential distribution and marketing partners.
' Helps avoid patent infringement.
' Timelines from concept to market lets you keep track of market potential build for a new product.
' Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Table of Content

1 Table of Contents 2
1.1 List of Tables 5

Alcon, Inc. Product Pipeline Analysis Page 1/5


1.2 List of Figures 6
2 Company Snapshot 7
2.1 Key Information 7
2.2 Company Overview 7
3 Alcon, Inc. Pipeline Products 8
3.1 Alcon, Inc. Product Pipeline Analysis 8
3.1.1 Alcon, Inc. Pipeline Products By Equipment Type 8
3.1.2 Alcon, Inc. Pipeline Products By Development Stage 9
3.1.3 Alcon, Inc. Pipeline Products By Therapy Area 9
3.1.4 Alcon, Inc. Pipeline Products By Clinical Trials 9
3.1.5 Alcon, Inc. Pipeline Products By News Summary 9
3.2 AcrySof ReSTOR IOL +3.0 Add 10
3.2.1 Product Status 10
3.2.2 Product Description 10
3.2.3 Product Milestone 10
3.2.4 AcrySof ReSTOR IOL +3.0 AddClinical Trials 1 11
3.2.5 AcrySof ReSTOR IOL +3.0 AddClinical Trials 2 12
3.3 AcrySof Low Power ReSTOR lens 12
3.4 AcrySof thin-profile IOL 13
3.5 AcrySof ReSTOR Toric IOL 14
3.6 AcrySof Angle-supported Phakic Lens 14
3.6.3 Product Milestone 15
3.6.4 Clinical Trials 15
3.7 New CONSTELLATION Vitreoretinal System 17
4 Recent Developments 18
4.1 Product News 18
4.1.1 Sep 15, 2008: Alcon Launches New AcrySof ReSTOR Intraocular Lens For Presbyopia Outside The US 18
4.1.2 Sep 12, 2008: Alcon Expands Refractive Surgery Options With The Introduction Of The AcrySof Phakic Intraocular Lens
Outside The US 18
4.1.3 Jun 25, 2008: Alcon Enters Into Patent Cross-Licensing Agreement With AMO 18
4.1.4 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA 19
4.1.5 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens Approved By FDA 19
4.1.6 Dec 18, 2006: Alcon Recalls 'Systane Free' Eye Drops 19
4.1.7 Dec 15, 2006: (ACL) Announces Voluntary Recall Of Systane(R) Free LIQUID GEL Lubricant Eye Drops In The United States,
Including Puerto Rico. 19
4.1.8 Oct 25, 2006: Children's Hospital of Austin is Helping Save Young Patients' Eyesight with New Technology. 19
4.1.9 Jun 02, 2006: Alcon gets U.S. FDA approval for Ladar6000 Excimer Laser, Wavefront-Guided Hyperopia. 20
4.1.10 May 21, 2006: AcrySof IQ IOL Designated as a New Technology Intraocular Lens 20
4.1.11 Oct 12, 2005: FDA Approves Alcon's OPTI-FREE RepleniSH MPDS 20
4.1.12 Jan 15, 2005: Combination system provides extra protection. 20



4.1.13 Mar 01, 2004: Surgeons laud various advantages of viscoelastic duo. 20
4.1.14 Apr 14, 2003: Alcon Introduces INFINITI Vision System, a Revolutionary Cataract Removal System 21
4.1.15 Feb 28, 2003: What's Coming in 2003 21
4.1.16 Oct 24, 2002: Alcon Reports Third Quarter Operating Results 21
4.2 Product Approvals 21
4.2.1 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA 21
4.2.2 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens Approved By FDA 21
4.2.3 Oct 12, 2005: FDA Approves Alcon's OPTI-FREE RepleniSH MPDS 22
5 Appendix 23
5.1 Methodology 23
5.1.1 Coverage 23
5.1.2 Secondary Research 24
5.1.3 Primary Research 24
5.1.4 Expert Panel Validation 25
5.2 Contact Us 25
5.3 About Global Markets Direct 25
5.4 Disclaimer 25

1.1 List of Figures
Figure 1: Global Markets Direct Methodology 23



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

Digital Copy--USD 750.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Alcon, Inc. Product Pipeline Analysis

Recommandé

Recommandé

Contenu connexe

Plus de ReportLinker.com

Plus de ReportLinker.com (20)

Dernier

Dernier (20)

Alcon, Inc. Product Pipeline Analysis